Caitlin Jomoc, OD
Optometrist · San Diego, CANPI 1861164642
Payments from drug & device makers
Across 34 payments — averaging $38.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$557
- Astellas Pharma US Inc$136
- Coopervision Inc.$103
- Tarsus Pharmaceuticals, Inc.$100
- Sun Pharmaceutical Industries Inc.$95
- Visioneering Technologies, Inc.$76
- plus $227 from 6 others
What the payments were for
- Food & beverage$1,293100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $557 |
| Astellas Pharma US Inc | 1 | $136 |
| Coopervision Inc. | 1 | $103 |
| Tarsus Pharmaceuticals, Inc. | 3 | $100 |
| Sun Pharmaceutical Industries Inc. | 4 | $95 |
| Visioneering Technologies, Inc. | 1 | $76 |
| Mallinckrodt Hospital Products Inc. | 3 | $71 |
| Bausch & Lomb Americas Inc. | 2 | $42 |
| Glaukos Corporation | 1 | $35 |
| Dompe US, Inc. | 1 | $34 |
| AbbVie | 1 | $28 |
| Thea Pharma Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$413
- Izervay$136
- Ortho-K Contact Lens$103
How this compares
$1,293 in reported general payments places this provider in the 65th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 16 | $629 |
| MoxifloxacinMoxifloxacin Hcl | 25 | $390 |
| ErythromycinErythromycin Base | 30 | $308 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 19 | $255 |
| Latanoprost | 22 | $120 |
Paid to pharmacies, not to this prescriber.
Other optometrist in San Diego
- Keith WanSan Diego$887K
- David GeffenSan Diego$384K
- Jason TuSan Diego$351K
- Dorothy WangSan Diego$312K
- Alicia LauSan Diego$300K
- Melody TavakoliSan Diego$267K
- Brian ChouSan Diego$243K
- Eric WhiteSan Diego$211K
- Elliott ShapiroSan Diego$135K
- Brittany McMurrenSan Diego$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.